Frédéric Bernier
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Forest ecology and management 4
-
- Diabetes Treatment and Management 2
- Co-authors
- Didier Bert (1 shared paper)Frédéric Danjon (1 shared paper)Mark R. Bakker (1 shared paper)Pierre Trichet (2 shared papers)Laurent Augusto (2 shared papers)Céline Meredieu (2 shared papers)David Achat (1 shared paper)Alejandro Conde (4 shared papers)
In The Last Decade
Frédéric Bernier
16 papers receiving 3.0k citations
Frédéric Bernier's Hit Papers
Peers
Comparison fields: 5 of 106
- Endocrinology, Diabetes and Metabolism 2.4k
- Pharmacology 321
- Nephrology 121
- Surgery 644
- Cardiology and Cardiovascular Medicine 300
Countries citing papers authored by Frédéric Bernier
This map shows the geographic impact of Frédéric Bernier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bernier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bernier more than expected).
Fields of papers citing papers by Frédéric Bernier
This network shows the impact of papers produced by Frédéric Bernier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bernier. The network helps show where Frédéric Bernier may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Bernier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 2018 | 206 | |
| 4 | 2014 | 45 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 8 | |
| 8 | 1980 | 4 | |
| 9 | 1974 | 4 | |
| 10 | 1970 | 3 | |
| 11 | 2012 | 2 | |
| 12 | 2005 | 1 | |
| 13 | 2025 | 1 | |
| 14 | Plantation d’essences feuillues dans le massif des Landes de Gascogne : diversifier et produire ? | 2016 | 1 |
| 15 | 2024 | 1 | |
| 16 | 1971 | 1 |
About Frédéric Bernier
Frédéric Bernier is a scholar working on Nature and Landscape Conservation, Endocrinology, Diabetes and Metabolism, Organic Chemistry, Agronomy and Crop Science and Inorganic Chemistry, having authored 16 papers that have together received 3.1k indexed citations. Recurring topics across this work include Forest ecology and management (4 papers), Crystal structures of chemical compounds (2 papers), Bioenergy crop production and management (2 papers), Organometallic Compounds Synthesis and Characterization (2 papers), Genetic and phenotypic traits in livestock (2 papers), Diabetes Treatment and Management (2 papers), Plant Water Relations and Carbon Dynamics (1 paper) and Free Radicals and Antioxidants (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.4k citations), Pharmacology (321 citations), Nephrology (121 citations), Surgery (644 citations) and Cardiology and Cardiovascular Medicine (300 citations). Frédéric Bernier has collaborated with scholars based in France, Spain and Germany. Frequent co-authors include Didier Bert, Frédéric Danjon, Mark R. Bakker, Pierre Trichet, Laurent Augusto, Céline Meredieu, David Achat, Alejandro Conde, Rafael Márquez and Rodolfo Márquez. Their work appears in journals such as The Lancet, Molecular Biology and Evolution, Diabetes Care, GCB Bioenergy and Global Ecology and Biogeography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.